Analysts Shared Their Read on 2 Stocks: Apricus Biosciences, Inc. (APRI), Nutanix, Inc. (NTNX)

The opening price for Apricus Biosciences, Inc. (NASDAQ:APRI) was $1.6 and the volume amounted to 0.24 million shares which compares with the average volume of 0.22 million shares. The company stock experienced a 5% move to arrive at $1.68.

Apricus Biosciences, Inc. (APRI) Analyst Opinion

Apricus Biosciences, Inc. has a consensus outperform rating from 2 Wall Street analysts, and the number of shares currently sold short amount to at least 8.64% of shares outstanding. The stock sank -0.59% last month and is up 29.23 this year. Wall Street is only getting more bullish on the stock, with 2 of analysts who cover APRI having a buy-equivalent rating. Analysts have placed a $3.5 price target on Apricus Biosciences, Inc., suggesting a 108.33% gain from recent close. It’s currently trading about -58.72% below its 52-week high.

Apricus Biosciences, Inc. (NASDAQ:APRI) Intraday View

This stock (APRI) is ahead of its 52-week low with 95.35%. Its last month’s stock price volatility remained 5.57% which for the week stands at 6.85%. The share price has moved forward from its 20 days moving average, trading at a distance of 4.62% and stays -2.28% away from its 50 days moving average. Over the last five days, shares have managed 5% gains and now is up 5.23% since hitting its 200-day moving average of $1.43. Apricus Biosciences, Inc. (APRI) has made its way to a 12-month gain of 32.28%.

Turning to Nutanix, Inc. (NASDAQ:NTNX), its shares were trading at $34.04 a retreat of $-2.02, on the trading floor. The stock, after opening at $36.02, touched a high of $36.9399 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. Nutanix, Inc. has 6 buy ratings, 4 holds and 0 sells even after the stock tumbled -11.08% from its high of $38.28 to a $5.23 billion market value through last close.

Nutanix, Inc. (NTNX) Consensus Price Target

The company’s consensus rating on Reuter’s scale slipped from 2.12 to 2 during a month. Analysts set a 12-month price target of $32.53 a share. The target implies a -4.44% decrease from where the shares are currently trading. Also, the current price highlights a discount of 49.82% to analysts’ high consensus price target.

Nutanix, Inc. (NASDAQ:NTNX) Intraday Trading

The counter witnessed a trading volume of 8.36 million shares versus an average volume of 4.31 million shares during last trading session. Its last month’s stock price volatility remained 7.85% which for the week approaches 4.67%. The lowest price the stock reached in the last trading day was $33.86 and compares with the $14.38 52-week low. The stock recovered 136.72% since its low point and has performed 28.16% year-to-date.

Previous articleAnalyst Commentary On National CineMedia, Inc. (NCMI), FibroGen, Inc. (FGEN)
Next articleWall Street Stock Recommendations: Office Depot, Inc. (ODP), SendGrid, Inc. (SEND)